Terms: = Germ cell tumor AND TPR, P12270, 7175 AND Prognosis
6 results:
1. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting prognosis.
Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X
Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322
[TBL] [Abstract] [Full Text] [Related]
2. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
Li Y; Feng Y; Luo F; Peng G; Li Y
Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
[TBL] [Abstract] [Full Text] [Related]
3. Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.
Zhang E; Chen Y; Bao S; Hou X; Hu J; Mu OYN; Song Y; Shan L
Hum Genomics; 2021 Aug; 15(1):53. PubMed ID: 34384498
[TBL] [Abstract] [Full Text] [Related]
4. FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma.
Romano S; Xiao Y; Nakaya M; D'Angelillo A; Chang M; Jin J; Hausch F; Masullo M; Feng X; Romano MF; Sun SC
Nucleic Acids Res; 2015 Aug; 43(14):6983-93. PubMed ID: 26101251
[TBL] [Abstract] [Full Text] [Related]
5. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.
Dubuc AM; Remke M; Korshunov A; Northcott PA; Zhan SH; Mendez-Lago M; Kool M; Jones DT; Unterberger A; Morrissy AS; Shih D; Peacock J; Ramaswamy V; Rolider A; Wang X; Witt H; Hielscher T; Hawkins C; Vibhakar R; Croul S; Rutka JT; Weiss WA; Jones SJ; Eberhart CG; Marra MA; Pfister SM; Taylor MD
Acta Neuropathol; 2013 Mar; 125(3):373-84. PubMed ID: 23184418
[TBL] [Abstract] [Full Text] [Related]
6. Malignant cerebral glioma--II: Perspectives of patients and relatives on the value of radiotherapy.
Davies E; Clarke C; Hopkins A
BMJ; 1996 Dec; 313(7071):1512-6. PubMed ID: 8978225
[TBL] [Abstract] [Full Text] [Related]
